alanyl-alanyl-phenylalanine chloromethyl ketone has been researched along with Carcinoma, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carcoforo, P; Castelli, C; Fortini, C; Gavioli, R; Marescotti, D; Masucci, M; Preta, G | 1 |
1 other study(ies) available for alanyl-alanyl-phenylalanine chloromethyl ketone and Carcinoma, Anaplastic
Article | Year |
---|---|
Inhibition of serine-peptidase activity enhances the generation of a survivin-derived HLA-A2-presented CTL epitope in colon-carcinoma cells.
Topics: Amino Acid Chloromethyl Ketones; Aminopeptidases; Antigen Presentation; Antigens, Neoplasm; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Epitopes, T-Lymphocyte; HLA-A2 Antigen; Humans; Inhibitor of Apoptosis Proteins; Lymphocyte Activation; Microtubule-Associated Proteins; Neoplasm Proteins; Proteasome Endopeptidase Complex; Serine Endopeptidases; Serine Proteinase Inhibitors; Survivin; T-Lymphocytes, Cytotoxic | 2008 |